Eterna Therapeutics
ERNA
#10008
Rank
ยฃ9.57 M
Marketcap
ยฃ0.15
Share price
5.73%
Change (1 day)
-88.97%
Change (1 year)

P/S ratio for Eterna Therapeutics (ERNA)

P/S ratio as of April 2025 (TTM): 21.9

According to Eterna Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.49. At the end of 2024 the company had a P/S ratio of 22.3.

P/S ratio history for Eterna Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202422.3-84.36%
2023143
2022N/A
2021N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.21-94.46%๐Ÿ‡บ๐Ÿ‡ธ USA
11.7-46.34%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
2.73-87.55%๐Ÿ‡ซ๐Ÿ‡ท France
6.71-69.34%๐Ÿ‡บ๐Ÿ‡ธ USA
0.2168-99.01%๐Ÿ‡ฆ๐Ÿ‡บ Australia
1.02-95.34%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel